105 studies found for:    infant care | Open Studies | NIH
Show Display Options
Rank Status Study
21 Recruiting Implementing a Comprehensive Prevention of Mother-to-Child Transmission of HIV Program for South African Couples
Conditions: HIV;   Pregnancy
Intervention: Behavioral: Protect your family
22 Recruiting Promoting Health in Pregnancy and Postpartum
Conditions: Obesity;   Pregnancy;   Overweight
Interventions: Behavioral: Lifestyle Intervention;   Behavioral: Standard Care
23 Unknown  Systems Analysis and Improvement to Optimize pMTCT
Condition: HIV
Intervention: Other: pMTCT systems analysis and improvement
24 Recruiting Testosterone and Cortisol Levels in Infants
Conditions: Infant, Premature;   Infant, Very Low Birth Weight
Intervention:
25 Recruiting Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents
Condition: HIV Infections
Interventions: Drug: Dolutegravir (DTG) film-coated tablets;   Drug: DTG granules for suspension;   Drug: DTG dispersible tablets
26 Recruiting Contingency Management for Smoking Cessation in Pregnant Minority Women
Condition: Cigarette Smoking
Interventions: Other: Quit Smoking Now (QSN);   Behavioral: Prize-based Contingency Management (CM)
27 Recruiting An Observational Study of Hepatitis C Virus in Pregnancy
Condition: Hepatitis C
Intervention:
28 Recruiting Evaluating the Safety and Pharmacokinetics of VRC01, a Potent Anti-HIV Neutralizing Monoclonal Antibody, in HIV-1-Exposed Infants
Condition: HIV Infections
Intervention: Biological: VRC01
29 Unknown  Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Condition: Nosocomial Infections
Interventions: Drug: Talactoferrin;   Drug: Placebo
30 Recruiting Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Clear Cell Adenocarcinoma;   Fallopian Tube Endometrioid Adenocarcinoma;   Fallopian Tube Mucinous Adenocarcinoma;   Fallopian Tube Serous Adenocarcinoma;   Fallopian Tube Transitional Cell Carcinoma;   Malignant Ovarian Brenner Tumor;   Malignant Ovarian Mixed Epithelial Tumor;   Ovarian Clear Cell Adenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Adenocarcinoma;   Ovarian Serous Adenocarcinoma;   Ovarian Transitional Cell Carcinoma;   Primary Peritoneal Serous Adenocarcinoma;   Stage IIA Fallopian Tube Cancer;   Stage IIA Ovarian Cancer;   Stage IIB Fallopian Tube Cancer;   Stage IIB Ovarian Cancer;   Stage IIC Fallopian Tube Cancer;   Stage IIC Ovarian Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Primary Peritoneal Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Primary Peritoneal Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Cancer;   Stage IIIC Primary Peritoneal Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Cancer;   Stage IV Primary Peritoneal Cancer;   Undifferentiated Fallopian Tube Carcinoma;   Undifferentiated Ovarian Carcinoma
Interventions: Behavioral: Behavioral Dietary Intervention;   Behavioral: Compliance Monitoring;   Other: Counseling;   Other: Educational Intervention;   Behavioral: Exercise Intervention;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
31 Recruiting Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
Condition: Childhood Acute Lymphoblastic Leukemia in Remission
Interventions: Behavioral: behavioral intervention;   Drug: mercaptopurine;   Procedure: standard follow-up care;   Behavioral: compliance monitoring;   Other: questionnaire administration;   Other: laboratory biomarker analysis
32 Recruiting Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at High Risk of Acquiring HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir
33 Recruiting Perinatal mHealth Intervention in Guatemala
Conditions: Pregnancy;   Prenatal Care
Intervention: Device: mHealth
34 Recruiting Neuropsychological and Behavioral Testing in Younger Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity;   Childhood Cancer;   Cognitive/Functional Effects;   Neurotoxicity;   Psychosocial Effects of Cancer and Its Treatment;   Radiation Toxicity
Interventions: Procedure: psychosocial assessment and care;   Procedure: cognitive assessment;   Other: quality-of-life assessment;   Other: questionnaire administration
35 Recruiting A Randomized Trial of Induction Versus Expectant Management
Condition: Labor and Delivery
Intervention: Procedure: Elective Induction of Labor
36 Unknown  Maternal Genitourinary Infections and Adverse Perinatal Outcomes
Condition: Maternal Infection Affecting Newborn
Intervention: Other: Screening treatment and referral
37 Recruiting PREPARE: A Randomized Trial of a Pre-pregnancy Weight Loss Intervention
Conditions: Overweight;   Obese
Interventions: Behavioral: Weight management;   Other: Usual Care Control
38 Recruiting Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Clear Cell Adenocarcinoma;   Fallopian Tube Endometrioid Adenocarcinoma;   Fallopian Tube Mucinous Adenocarcinoma;   Fallopian Tube Serous Adenocarcinoma;   Fallopian Tube Transitional Cell Carcinoma;   Ovarian Clear Cell Adenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Adenocarcinoma;   Ovarian Seromucinous Carcinoma;   Ovarian Serous Adenocarcinoma;   Ovarian Transitional Cell Carcinoma;   Primary Peritoneal Serous Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Undifferentiated Fallopian Tube Carcinoma;   Undifferentiated Ovarian Carcinoma
Interventions: Drug: Cediranib Maleate;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib;   Drug: Paclitaxel;   Drug: Pegylated Liposomal Doxorubicin Hydrochloride;   Other: Questionnaire Administration;   Drug: Topotecan Hydrochloride
39 Not yet recruiting Web-based Implementation for the Science of Enhancing Resilience Study
Conditions: Burnout, Professional;   Resilience, Psychological
Interventions: Behavioral: WISER 1;   Behavioral: WISER 2;   Behavioral: WISER 3;   Behavioral: WISER 4;   Behavioral: WISER 5;   Behavioral: WISER 6
40 Recruiting Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants
Condition: Ureaplasma Infections
Interventions: Drug: Azithromycin;   Drug: Placebo (for azithromycin)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years